BNGO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bionano Genomics Inc (BNGO) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock lacks positive momentum, has weak financial performance, and no significant trading or news catalysts. A 'hold' position is recommended until clearer growth signals or catalysts emerge.
The MACD is slightly positive but contracting, RSI is neutral at 46.635, and moving averages are converging, indicating no clear trend. The stock is trading below the pivot level of 1.162, with key support at 1.109 and resistance at 1.215.
Gross margin increased by 2.13% YoY, indicating slight operational efficiency improvement.
No recent news, trading trends, or significant catalysts. The stock has a 50% chance to decline in the next day and week.
In Q4 2025, revenue was $7.95M (-2.60% YoY), net income was -$7.93M (-60.58% YoY), and EPS was -0.77 (-93.70% YoY). Gross margin improved slightly to 42.75%.
No recent analyst ratings or price target changes available.
